The Effect of Methylated Vitamin B Complex on Depression
The proposed study is a 60-day, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of a methylated vitamin B complex nutritional supplement (Max Stress B™) for improving depressive and anxiety symptoms according to the Beck Depression and Anxiety Inventories, respectively, in 60 patients (18+ years of age) diagnosed with major depression or other forms of depressive disorders and an elevated level of homocysteine (> 10 µmol/L) at baseline. Secondary outcomes will include anthropometrics for body composition, blood pressure and pulse, level of physical activity, dietary intake, and quality of life. Participants will be assessed at baseline and 30 and 60 days. The study will consist of two treatment arms: (a) vitamin B complex nutritional supplement and (b) placebo.
The information obtained in this study will help in determining the efficacy of using nutritional supplements for improving the outcomes of people with depression.
100 项与 Premier Research Labs LP 相关的临床结果
0 项与 Premier Research Labs LP 相关的专利(医药)
100 项与 Premier Research Labs LP 相关的药物交易
100 项与 Premier Research Labs LP 相关的转化医学